These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33528904)

  • 1. Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
    Haidar A; Yale JF; Lovblom LE; Cardinez N; Orszag A; Falappa CM; Gouchie-Provencher N; Tsoukas MA; El Fathi A; Rene J; Eldelekli D; Lanctôt SO; Scarr D; Perkins BA
    Diabetes Obes Metab; 2021 Jun; 23(6):1272-1281. PubMed ID: 33528904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.
    Cohen E; Tsoukas MA; Legault L; Vallis M; Von Oettingen JE; Palisaitis E; Odabassian M; Yale JF; Garfield N; Gouchie-Provencher N; Rutkowski J; Jafar A; Ghanbari M; Haidar A
    Lancet Digit Health; 2024 Jul; 6(7):e489-e499. PubMed ID: 38906614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.
    Tsoukas MA; Cohen E; Legault L; von Oettingen JE; Yale JF; Vallis M; Odabassian M; El Fathi A; Rutkowski J; Jafar A; Ghanbari M; Gouchie-Provencher N; René J; Palisaitis E; Haidar A
    Diabetes Obes Metab; 2021 Sep; 23(9):2090-2098. PubMed ID: 34047449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
    Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jafar A; Devaux M; Ghanbari M; Rabasa-Lhoret R
    Diabetes Care; 2023 Jul; 46(7):1372-1378. PubMed ID: 37134305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
    Haidar A; Lovblom LE; Cardinez N; Gouchie-Provencher N; Orszag A; Tsoukas MA; Falappa CM; Jafar A; Ghanbari M; Eldelekli D; Rutkowski J; Yale JF; Perkins BA
    Nat Med; 2022 Jun; 28(6):1269-1276. PubMed ID: 35551290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study.
    Petruzelkova L; Neuman V; Plachy L; Kozak M; Obermannova B; Kolouskova S; Pruhova S; Sumnik Z
    Diabetes Technol Ther; 2023 May; 25(5):315-323. PubMed ID: 36826996
    [No Abstract]   [Full Text] [Related]  

  • 11. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Maltoni G; Allen JM; Nodale M; Kumareswaran K; Leelarathna L; Thabit H; Caldwell K; Wilinska ME; Calhoun P; Kollman C; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2014 Nov; 16(11):1174-8. PubMed ID: 24909206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
    Majdpour D; Tsoukas MA; Yale JF; El Fathi A; Rutkowski J; Rene J; Garfield N; Legault L; Haidar A
    Can J Diabetes; 2021 Dec; 45(8):734-742. PubMed ID: 33888413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
    Gingras V; Rabasa-Lhoret R; Messier V; Ladouceur M; Legault L; Haidar A
    Diabetes Metab; 2016 Feb; 42(1):47-54. PubMed ID: 26072052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial.
    Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jacobs PG; El-Fathi A; Rutkowski J; Messier V; Rabasa-Lhoret R
    Diabetes Technol Ther; 2021 Mar; 23(3):168-174. PubMed ID: 33050728
    [No Abstract]   [Full Text] [Related]  

  • 17. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
    Kariyawasam D; Morin C; Casteels K; Le Tallec C; Sfez A; Godot C; Huneker E; Garrec N; Benhamou PY; Polak M; Charpentier G; Franc S; Beltrand J
    Lancet Digit Health; 2022 Mar; 4(3):e158-e168. PubMed ID: 35216750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.
    Petrovski G; Campbell J; Pasha M; Hussain K; Khalifa A; Umer F; Almajaly D; Hamdar M; Heuvel TVD; Edd SN
    Diabetes Technol Ther; 2024 Mar; 26(S3):76-83. PubMed ID: 38377327
    [No Abstract]   [Full Text] [Related]  

  • 19. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial.
    Wilkinson T; Tomic D; Boyle E; Burren D; Elghattis Y; Jenkins A; Keesing C; Middleton S; Nanayakkara N; Williman J; de Bock M; Cohen ND
    BMJ Open; 2024 Feb; 14(2):e078171. PubMed ID: 38382954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.